WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to $349 a month

The announcements come days after President Donald Trump struck deals with Novo Nordisk and Eli Lilly to make their GLP-1s easier for Americans to access.

Raccontata dacnbc.comusatoday.com

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
cnbc.comStai leggendo7 mesi fa

Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to $349 a month

The announcements come days after President Donald Trump struck deals with Novo Nordisk and Eli Lilly to make their GLP-1s easier for Americans to access.

originale
usatoday.com7 mesi fa

Drugmaker cuts prices for Ozempic, Wegovy. Here's how much you will pay.

The maker of the weight loss and diabetes drugs Wegovy and Ozempic has cut the prices for most versions of the blockbuster medications.

Leggi questa versione → originale

Timeline cronologica

  1. lunedì 17 novembre 2025·cnbc.com

    Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to $349 a month

    The announcements come days after President Donald Trump struck deals with Novo Nordisk and Eli Lilly to make their GLP-1s easier for Americans to access.

  2. lunedì 17 novembre 2025·usatoday.com

    Drugmaker cuts prices for Ozempic, Wegovy. Here's how much you will pay.

    The maker of the weight loss and diabetes drugs Wegovy and Ozempic has cut the prices for most versions of the blockbuster medications.